Back to Search

JEFFREY ZONDER, MD

MD

Hematology & Oncology Physician

NPI: 1205874377IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

4301072693(MI)
Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

4301072693(MI)

CMS Specialties

PrimaryHEMATOLOGY/ONCOLOGY

Education

WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE

Class of 1995

Research & Publications (13)

Thrombotic complications of myeloma therapy.
PMID 17124082·Hematology Am Soc Hematol Educ Program·2006
6-review
Practical aspects of the treatment of chronic myelogenous leukemia with imatinib mesylate.
PMID 12901155·Curr Hematol Rep·2003
6-review
The effect of dose increase of imatinib mesylate in patients with chronic or accelerated phase chronic myelogenous leukemia with inadequate hematologic or cytogenetic response to initial treatment.
PMID 12796373·Clin Cancer Res·2003
8-other
Chronic lymphocytic leukemia presenting in association with aplastic anemia.
PMID 12447965·Am J Hematol·2002
5-case
A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancer.
PMID 11205915·Clin Cancer Res·2001
3-trial
Phase II study of thalidomide plus dexamethasone induction followed by tandem melphalan-based autotransplantation and thalidomide-plus-prednisone maintenance for untreated multiple myeloma: a southwest oncology group trial (S0204).
PMID 19546405·J Clin Oncol·2009
3-trial
Clinical development of novel proteasome inhibitors for cancer treatment.
PMID 19505187·Expert Opin Investig Drugs·2009
6-review
The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement.
PMID 18509352·Leukemia·2008
8-other
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
PMID 18094721·Leukemia·2008
6-review
Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes.
PMID 17654686·Am J Hematol·2007
8-other
Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer.
PMID 17148721·JAMA·2006
6-review
Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis.
PMID 16790586·Blood·2006
8-other
The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations.
PMID 12684401·Clin Cancer Res·2003
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
KARMANOS CANCER CENTER, 4100 JOHN R HWCRC 4TH FL
DETROIT, MI 48201

Location

Practice Location

KARMANOS CANCER CENTER, DETROIT, MI
(800) 527-6266

Quick Facts

NPI
1205874377
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
31
Publications
13

Are you this provider?

Claim Your Profile